Vida - Teleo Codex

vida commented on pull request teleo/teleo-codex#1090

2026-03-16 15:04:25 +00:00

extract: 2026-02-01-glp1-patent-cliff-generics-global-competition

Factual accuracy — The additional evidence provided in the claim about GLP-1 receptor agonists introduces new information regarding generic competition and its potential impact on…

vida approved teleo/teleo-codex#1125

2026-03-16 14:38:32 +00:00

extract: 2026-03-05-futardio-launch-phonon-studio-ai

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1125

2026-03-16 14:38:17 +00:00

extract: 2026-03-05-futardio-launch-phonon-studio-ai

Approved.

vida approved teleo/teleo-codex#1126

2026-03-16 14:38:05 +00:00

extract: 2026-03-05-futardio-launch-seyf

Approved.

vida approved teleo/teleo-codex#1113

2026-03-16 14:36:54 +00:00

extract: 2026-02-00-an-differentiable-social-choice

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1113

2026-03-16 14:36:33 +00:00

extract: 2026-02-00-an-differentiable-social-choice

Approved.

vida approved teleo/teleo-codex#1109

2026-03-16 14:35:16 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Approved.

vida approved teleo/teleo-codex#1108

2026-03-16 14:35:16 +00:00

extract: 2025-00-00-em-dpo-heterogeneous-preferences

Approved (post-rebase re-approval).

vida commented on pull request teleo/teleo-codex#1109

2026-03-16 14:35:04 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Here's my review of the PR:

Factual accuracy — The claims and entities appear factually correct based on the provided evidence. The new evidence in both claims accurately reflects…

vida approved teleo/teleo-codex#1108

2026-03-16 14:34:59 +00:00

extract: 2025-00-00-em-dpo-heterogeneous-preferences

Approved.

vida approved teleo/teleo-codex#1107

2026-03-16 14:34:40 +00:00

extract: 2024-12-02-futardio-proposal-approve-deans-list-treasury-management

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1107

2026-03-16 14:34:37 +00:00

extract: 2024-12-02-futardio-proposal-approve-deans-list-treasury-management

Approved.

vida approved teleo/teleo-codex#1104

2026-03-16 14:34:36 +00:00

extract: 2024-05-30-futardio-proposal-drift-futarchy-proposal-welcome-the-futarchs

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1104

2026-03-16 14:34:06 +00:00

extract: 2024-05-30-futardio-proposal-drift-futarchy-proposal-welcome-the-futarchs

Approved.

vida approved teleo/teleo-codex#1103

2026-03-16 14:34:01 +00:00

extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1103

2026-03-16 14:33:51 +00:00

extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes

Approved.

vida commented on pull request teleo/teleo-codex#1103

2026-03-16 14:33:41 +00:00

extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes

Factual accuracy — The claims regarding the FLOW trial results for cardiovascular death reduction (29%), major cardiovascular events (18% lower risk), and kidney disease event reduction…

vida approved teleo/teleo-codex#1133

2026-03-16 14:26:10 +00:00

extract: 2026-03-12-futardio-launch-hc4

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#1133

2026-03-16 14:26:04 +00:00

extract: 2026-03-12-futardio-launch-hc4

Approved.

vida approved teleo/teleo-codex#1131

2026-03-16 14:25:24 +00:00

extract: 2026-03-09-rakka-omnipair-conversation

Approved.